Inicio > PEÑARRUBIA PONCE, MARIA JESUS

PEÑARRUBIA PONCE, MARIA JESUS

PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Medicina, Dermatología y Toxicología
 
mariajesus.penarrubia@uva.es

Índice H en Scopus: 19
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66945]], camposKey:0006-4971 2021-04-08 Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome¿negative adult lymphoblastic leukemia18791894, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66946]], camposKey:0939-5555 2020-04-01 RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group799808, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61691]], camposKey:1664-2295 2020-01-01 Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52143]], camposKey:0902-4441 2020-01-01 Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia259270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47734]], camposKey:0019-9567 2018-01-01 Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47736]], camposKey:0925-5710 2017-01-01 Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice508516, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47739]], camposKey:0902-4441 2016-09-01 Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice297302, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47745]], camposKey:0361-8609 2015-01-01 Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68838]], camposKey:0902-4441 2014-11-01 Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia422428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22426]], camposKey:0210-5705 2014-01-01 Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56309]], camposKey:0210-5705 2014-01-01 Synchronic MALT lymphoma and carcinoid tumor of the ileum Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22427]], camposKey:0210-6523 2013-01-01 Linfoma de Hodgkin259271, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68846]], camposKey:0390-6078 2010-05-01 Long FLT3 internal tandem duplications and reduced PML-RAR¿ expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients745751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68849]], camposKey:0145-2126 2009-12-01 High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics17061709, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47750]], camposKey:0145-2126 2009-06-01 Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68852]], camposKey:0006-4971 2009-01-01 Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia148152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68150]], camposKey:1130-0108 2008-08-01 Jejunal mucormycosis in a patient with Hodgkin's lymphoma Mucormicosis yeyunal en paciente con linfoma de Hodgkin507510, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22429]], camposKey:0210-6523 2008-01-01 Nuevas perspectivas en el tratamiento y curación de las leucemias275288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47753]], camposKey:0929-5305 2006-01-01 Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages113120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47755]], camposKey:1130-0108 2005-09-01 Primary biliary cirrhosis, "sicca" syndrome and autoimmune hemolytic anemia [5] Cirrosis biliar primaria, síndrome "sicca" y anemia hemolítica autoinmune678679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22428]], camposKey:0210-6523 2005-01-01 Tratamiento del mieloma múltiple con trasplante autólogo de progenitores hematopoyéticos93109, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38347]], camposKey:0009-7330 2004-01-01 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction742748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47713]], camposKey:0300-8932 2004-01-01 Intracoronary stem cell transplantation in acute myocardial infarction Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14434]], camposKey:0300-8932 2004-01-01 Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47758]], camposKey:1466-4860 2003-08-11 Emphysematous gastritis and severe aplastic anemia8284][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30936]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46a5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46a6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46aa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46a8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d46a7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d5609, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d5ae7][][][][][][][][][][][][]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (25)

Ribera J.M.; Morgades M.; Ciudad J.; Montesinos P.; Esteve J.; Genesca E.; Barba P.; Ribera J.; Garcia-Cadenas I.; Moreno M.J.; Martinez-Carballeira D.; Torrent A.; Martinez-Sanchez P.; Monsalvo S.; Gil C.; Tormo M.; Artola M.T.; Cervera M.; Gonzalez-Campos J.; Rodriguez C.; Bermudez A.; Novo A.; Soria B.; Coll R.; Amigo M.L.; Lopez-Martinez A.; Fernandez-Martin R.; Serrano J.; Mercadal S.; Cladera A.; Gimenez-Conca A.; Peñarrubia M.J.; Abella E.; Vall-llovera F.; Hernandez-Rivas J.M.; Garcia-Guiñon A.; Bergua J.M.; de Rueda B.; Sanchez-Sanchez M.J.; Serrano A.; Calbacho M.; Alonso N.; Mendez-Sanchez J.A.; Garcia-Boyero R.; Olivares M.; Barrena S.; Zamora L.; Granada I.; Lhermitte L.; Feliu E.; Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome¿negative adult lymphoblastic leukemia . BLOOD 2021; 137(14): 1879-1894.

Enlace a la publicación
Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Convenios (8)

ESTUDIO FASE III, PROSPECTIVO, ALEATORIZADO, ABIERTO, CON DOS BRAZOS DE TRATAMIENTO, PARA EVALUAR LA TASA DE REMISIÓN LIBRE DE TRATAMIENTO (RLT) EN PACIENTES CON LMC CROMOSOMA FILADELFIA POSITIVO, DESPUÉS DE DOS DURACIONES DISTINTAS DE TRATAMIENTO DE CONSOLIDACIÓN CON NILOTINIB 300 MG BID. . Equipo Investigadores: PEÑARRUBIA PONCE, MARIA JESUS (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: NOVARTIS FARMACEUTICA SA .. 2013-06-13

Ver Todos
 

OTROS

Tesis doctorales (1)


 
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados